Suchergebnisse - "Nagata, Kazuma"

PubPharm (5)

1

Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrence

enthalten in: Investigational new drugs | 2023

von Shima, Y. | Sato, Y. | Morimoto, T. | +8

2

Predictive performance of PD-L1 tumor proportion score for nivolumab response evaluated using archived specimens in patients with non-small cell lung cancer experiencing a postoperative recurrence

enthalten in: Investigational new drugs | 2022

von Shima, Y. | Sato, Y. | Morimoto, T. | +8

3

Association Between Formalin Fixation Time and Programmed Cell Death Ligand 1 Expression in Patients With Non-Small Cell Lung Cancer

enthalten in: Anticancer research | 2019

von Kawachi, H. | Fujimoto, D. | Yamashita, D. | +12

4

Comparison of PD-L1 Assays in Non-small Cell Lung Cancer : 22C3 pharmDx and SP263

enthalten in: Anticancer research | 2018

von Fujimoto, D. | Yamashita, D. | Fukuoka, J. | +12

5

Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease : A Matched Case-control Study

enthalten in: Clinical lung cancer | 2018

von Fujimoto, D. | Sato, Y. | Morimoto, T. | +10

1
[1]